You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Color Genomics' kit is designed for the unmonitored self-collection of nasal swab specimens for SARS-CoV-2 testing.
Grassroots efforts are leading the way in a number of commercial and non-commercial screening tests in development.
News items for the week of July 27, 2020.
A number of diagnostic labs have considered saliva-based SARS-CoV-2 testing but decided against it, while other groups continue to pursue it.
Issued last week, the guidance said insurers were not required to reimburse such testing, which could impact coverage in schools, workplaces, and other settings.
With students and faculty scheduled to return in a few months, institutions are reaching out to secure testing to help keep the virus in check on campus.
Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.
The test does not require thermal cycling and uses a colorimetric readout, making it more amenable to high-throughput automation and rapid scale-up, the company said.
Color is opening a lab dedicated to SARS-CoV-2 testing and adapting its software infrastructure to enable physicians to order tests and return results.
Many companies and counselors see the COVID-19 pandemic as a catalyst for moving germline risk testing into a digital-first healthcare model.